Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward E Graves

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
Radiation Oncology (London, England)|January 21, 2012
Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's diseaseDiane Tseng, Leelanand P Rachakonda, Zheng Su, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2010
Postradiation metabolic tumor volume predicts outcome in head-and-neck cancerJames D Murphy, Trang H La, Karen Chu, et al.
Clinical Lung Cancer|June 28, 2011
Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancerPercy Lee, Jose G Bazan, Philip W Lavori, et al.
Scientific Reports|October 7, 2015
Molecular Magnetic Resonance Imaging of Tumor Response to TherapyAdam J Shuhendler, Deju Ye, Kimberly D Brewer, et al.
Cancer Research|January 31, 2009
The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growthKevin L Bennewith, Xin Huang, Christine M Ham, et al.
Science Advances|July 3, 2026
A targetable FTO/SLC7A11/CBS/CTH axis controls cysteine metabolism, growth and survival in NSCLCNishanth Kuganesan, Margaret Pan, Haowen Jiang, et al.
Frontiers in Oncology|June 20, 2019
FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot StudySusan M Hiniker, Quaovi Sodji, Andrew Quon, et al.
Cancer Research|June 20, 2012
Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancerViswam S Nair, Olivier Gevaert, Guido Davidzon, et al.
Cancers|April 30, 2021
Pharmacological Regulation of Tumor Hypoxia in Model Murine Tumors and Spontaneous Canine TumorsMartin Benej, Jinghai Wu, McKenzie Kreamer, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2010
18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapyDevin Schellenberg, Andy Quon, A Yuriko Minn, et al.
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Radiation Oncology (London, England)|January 21, 2012
Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's diseaseDiane Tseng, Leelanand P Rachakonda, Zheng Su, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2010
Postradiation metabolic tumor volume predicts outcome in head-and-neck cancerJames D Murphy, Trang H La, Karen Chu, et al.
Clinical Lung Cancer|June 28, 2011
Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancerPercy Lee, Jose G Bazan, Philip W Lavori, et al.
Scientific Reports|October 7, 2015
Molecular Magnetic Resonance Imaging of Tumor Response to TherapyAdam J Shuhendler, Deju Ye, Kimberly D Brewer, et al.
Cancer Research|January 31, 2009
The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growthKevin L Bennewith, Xin Huang, Christine M Ham, et al.
Science Advances|July 3, 2026
A targetable FTO/SLC7A11/CBS/CTH axis controls cysteine metabolism, growth and survival in NSCLCNishanth Kuganesan, Margaret Pan, Haowen Jiang, et al.
Frontiers in Oncology|June 20, 2019
FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot StudySusan M Hiniker, Quaovi Sodji, Andrew Quon, et al.
Cancer Research|June 20, 2012
Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancerViswam S Nair, Olivier Gevaert, Guido Davidzon, et al.
Cancers|April 30, 2021
Pharmacological Regulation of Tumor Hypoxia in Model Murine Tumors and Spontaneous Canine TumorsMartin Benej, Jinghai Wu, McKenzie Kreamer, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2010
18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapyDevin Schellenberg, Andy Quon, A Yuriko Minn, et al.
Pageof 12